We don't know whether the most recent response to this request contains information or not – if you are Ita Fitzgerald please sign in and let everyone know.

Utilisation data of clozapine and lithium in Liberia

We're waiting for Ita Fitzgerald to read a recent response and update the status.

Ita Fitzgerald

Dear Ministry of Health and Social Welfare,

I hope this message finds you well.

Pursuant to the **Freedom of Information Act, 2010 I respectfully request access to aggregated statistical data held by the Ministry of Health concerning the prescribing, dispensing, procurement, distribution, reimbursement, utilisation, or consumption of the following medicinal products during the period 2014–2025 (or the longest period available):

Lithium (ATC N05AN01), including all lithium carbonate and lithium citrate products.
Clozapine (ATC N05AH02), including all clozapine-containing products.

I kindly request that the data be provided separately for lithium and clozapine and, where possible, separately for each corresponding product and strength.

Specifically, I request annual data for all products containing the above active substances, including, where available:

* Brand name.
* Strength.
* Pack size.

For each product and for each year, I respectfully request the following information, where available:

* Number of packs dispensed, supplied, procured, distributed, reimbursed, or otherwise provided.
* Number of tablets, capsules, vials, or other dosage units dispensed, supplied, procured, distributed, reimbursed, or otherwise provided.
* Utilisation or consumption volume.
* Procurement, purchasing, reimbursement, or expenditure data associated with these medicines.
* Any reports, statistical summaries, administrative datasets, spreadsheets, database extracts, or other records relating to the utilisation of lithium- or clozapine-containing products.

This request concerns only aggregated statistical and administrative information and does not seek personal data or information capable of identifying individual patients.

Yours faithfully,

Ita Fitzgerald MPharm, MSc, MPSI, MCMHP, PhD
Advanced Specialist Pharmacist (Mental Health), St. Patrick's University Hospital, James' St., Dublin 8, Ireland.
Adjunct Senior Clinical Lecturer, School of Pharmacy, University College Cork.
Honorary Clinical Lecturer, Royal College of Surgeons in Ireland.
01 2493262

Mail Delivery System,

2 Attachments

  • Attachment

    attachment.delivery status

    0K Download

  • Attachment

    Freedom of Information request Utilisation data of clozapine and lithium in Liberia.txt

    3K View Download

This message was created automatically by mail delivery software.

A message that you sent could not be delivered to one or more of its
recipients. This is a permanent error. The following address(es) failed:

[MOHSW request email]
host gmail-smtp-in.l.google.com [2a00:1450:4009:c19::1b]
SMTP error from remote mail server after RCPT TO:<[MOHSW request email]>:
550-5.1.1 The email account that you tried to reach does not exist. Please try
550-5.1.1 double-checking the recipient's email address for typos or
550-5.1.1 unnecessary spaces. For more information, go to
550 5.1.1 https://support.google.com/mail/?p=NoSuc... 5b1f17b1804b1-4926908e84csi115330775e9.15 - gsmtp

We don't know whether the most recent response to this request contains information or not – if you are Ita Fitzgerald please sign in and let everyone know.